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Introduction
An imbalance between endogenous antioxidant defense 
system and reactive oxygen species (ROS) level in the body 
causes oxidative stress, which is associated with overpro-
duction of free radicals from various liver disorders, such 
as alcoholic liver damage, non-alcoholic fatty liver dis-
ease and drug-induced liver injury (1,2). The liver is an 
important target of the toxicity of drugs and xenobiotics 
(3). Recently, natural agents with improved effectiveness 
and safety profiles as a therapy for liver disease have been 
extensively sought because the administration of drugs 
sometimes meets with limited therapeutic success and is 
usually associated with serious complications, especially 
the long-term use (4,5). ROS derived from many sources 
influence macromolecules in the liver result in hepatotox-
icity (6). In general, ROS can be scavenged by detoxifying 
systems within the body, such as glutathione, glutathione 
peroxidase, and catalase (7). However, quantities of ROS 
that overwhelm the capacity of the body’s defence system 
lead to a disturbance of homoeostasis in ROS production 
and antioxidant defence. Which in turn eventually dam-
ages biological molecules and key cellular components 
and processes such as lipid peroxidation, enzyme inactiva-
tion, and oxidative DNA damage (8). Dietary antioxidant 
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Introduction: Artemisia absinthium L. (AA) is a large, diverse genus of the family Asteraceae. AA 
has long been used as customary herbal medicine in world for the treatment of gastric pain, cardiac 
stimulation, improvement of memory and for the restoration of declined mental function. The aim 
of present study was to evaluate the hepatoprotective effects of AA on some factors reflecting the 
development of oxidative toxic stress in plasma. 
Methods: Twenty male rats were equally divided in to 4 groups (5 rats each). Group I acted 
as control (received normal salin). Treatment groups were II, III and IV which were given 
Artemisia 10, 50 and 100 mg/kg/day respectively only by gavage for 24 hours. After treatment, 
blood specimens were collected. Liver enzymes such as aspartate aminotransferase (AST) and 
alanine aminotransferase (ALT) with total antioxidant power (TAP) and total thiol groups (TTG) 
concentrations were measured. 
Results: Levels of ALT, AST and TTG were decreased in the group II compared to the control 
(group I). ALT and AST in 50 mg/kg group was observed compared with control group. Also, TTG 
increased in Artemisia 50 mg/kg group compared to control group. 
Conclusion: Results suggests that alcoholic extract of Artemisia can ameliorate liver toxicity in 
rats through reducing the serum levels of ALT, AST, and oxidative damage.
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supplementation may help to restore this balance eventu-
ally inhibition of hepatotoxicity (9,10). Therefore, plant 
products or alternative medicines that could limit ROS-
mediated injuries are essentially needed to protect aid in 
the protection the liver from against all types of possible 
damage (11,12). Artemisia is a large, diverse genus of the 
family Asteraceae. Artemisia absinthium (AA), which is 
also known as ‘sweet wormwood’ and ’Qinghao’ has tra-
ditionally been used in traditional Chinese medicine for 
treatment of fever and chills (13). In particular, Artemisia 
and its derivatives have been used clinically in the treat-
ment of drug-resistant malaria while they were reported 
to have several bioactive functions including antitumor 
and anti-inflammatory activities (14-16). In addition, 
coumarins, flavonoids, and other terpenoids constituents 
present in AA are also reported to have significant phar-
macological activities such as antitumor and antibacterial 
activities that contribute to the therapeutic effects of the 
herb (17,18). The aim of the present study was to evalu-
ate the hepatoprotective effects of AA on some factors re-
flecting associated with the development of oxidative toxic 
stress in plasma. 
Materials and methods
Chemicals and reagents
Dithiobis-(2-nitrobenzoic acid) (DTNB) and Tris base, 
2,4,6-tripyridyl-s-triazine (TPTZ) from Merck Chemical 
Co. (Tehran) and alanine aminotransferase (ALT) & as-
partate aminotransferase (AST) kit from Parsazemon Co. 
(Tehran) were used in this study.
Plant material and preparation of extract
Aerial parts of the plant AA were procured from herbs 
stores. The taxonomic identity of the plant material was 
authenticated by Herbarium Unit of the Faculty of Phar-
macy, Hamadan University of Medical Sciences, Hama-
dan, Iran with a deposition specimen holder (No: 220). 
The dried aerial parts of the plant were milled to a fine 
powder using an electric blender. The methanol extract 
was prepared by extracting 50 g of the powdered plant ma-
terial using soxhlet apparatus (20 hours). Thereafter, the 
resulting methanol extract was reduced in vacuo (40°C), 
freeze dried and stored at 4°C until further used. The yield 
was 11.69% (w/w).
Animals and treatments
 20 Wistar rats (200 ± 20 g) were purchased from the Ani-
mal Center of Pastor Institute, Wuhan University, Wuhan, 
China. They were housed on 12 hours light–dark cycle at 
25 ± 2°C in relative humidity of 30%-60%, and maintained 
on a standard pellet diet and water ad libitum. The study 
received clearance from the Institutional Animal Ethical 
Committee of the Hamadan University of Medical Sci-
ences, Hamadan, Iran.
The experimental animals were divided into 4 equal 
groups: Group I acted as control (received nothing). 
Treatment groups were II, III and IV which were respec-
tively given Artemisia 10, 50 and 100 mg/kg/day by gavage 
for 24 hours (Group I (control), while group II was given 
Artemisia (10 mg/kg/day). Animals of groups III received 
only Artemisia (50 mg/kg/day). Group IV was given Ar-
temisia (100 mg/kg/day) with gavage for 24 hours. After 
treatment, blood specimens were collected. 
Serum biochemical analysis 
Blood specimens were collected from the abdominal aor-
ta. After centrifuging at 3000 g for 15 minutes, the serum 
was separated and stored in -80°C. The serum levels of 
AST and alanine transaminase ALT were determined by 
using autoanalyzer.
Determination of antioxidative biomarkers 
Assay of total antioxidant power 
Total antioxidant power (TAP) was measured by ferric 
reducing ability of plasma (FRAP) method. This method 
is based on the ability of plasma in reducing Fe3+ to Fe2+ 
in the presence of TPTZ. The reaction of Fe2+ and TPTZ 
gives a complex with a blue color and maximum absor-
bance in 593 nm (19).
Assay of total thiol groups 
To evaluate the plasma total thiol groups (TTG), DTNB 
was used as a reagent. DTNB reacts with thiol molecules 
and creates a yellow complex which has good absorbance 
at 412 nm in spectrophotometer (20).
Statistical analysis
All experiments were done in triplicate and results were 
reported as mean ± SEM (n = 5). The data were analyzed 
by one-way analysis of variance (ANOVA). Statistically 
significant effects were further analyzed. Means were also 
compared using Tukey’s multiple range tests. Statistical 
significance was determined at P < 0.05.
Results
Table 1 shows the mean ± SE of variables related to either 
oxidative stress or liver function in the animals tests. A 
significant increase (P = 0.041) in TTG was observed in 
the group II as compared to control group ( group I). ALT 
of animals-treated with Artemisia 50 mg/kg were signifi-
cantly (P = 0.046) lower than that of control group. Levels 
of ALT in the group II 50 mg/kg Artemisia were signifi-
cantly (P = 0.046) lower than those of the control group 
(group I). Also, 50 mg/kg Artemisia, reduced AST, with 
respect to the control group (P = 0.035). No significant dif-
ferences were observed in the TAP between the groups.
Discussion
This study was aimed to evaluate the hepatoprotective ef-
fects of AA on some factors reflecting the development 
of oxidative toxic stress in plasma. Administration of 
hydroalcoholic extract of AA would improved the liver 
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function and the level of oxidative stress parameters such 
as TTG in blood. Free radicals are the initiators of a re-
dox reaction cascade, which may lead to changes of the 
chemical structure of biological macromolecules, such as 
proteins, lipids and DNA, or trouble of human cell me-
tabolism or even tissue injury (21). In vitro and in vivo 
studies reported the antioxidant capacity of several species 
of medicinal plants, acting at cellular level, through cell 
growth stimulation, membrane potential stabilizing or at 
molecular level, through ROS scavenging, lipid peroxida-
tion, etc. (22). Also, for the evaluation of liver injury serum 
concentrations of the most commonly used biochemical 
markers, ALT and AST were determined. Increased levels 
of these specific hepatic marker enzymes after chemical or 
immunological intoxication, compared to control rats, in-
dicated considerable hepato-cellular damage and resulting 
leakage of cytosolic contents into the systemic circulation 
(23). AA extract seems to be able to preserve the structural 
integrity of the hepatocellular membrane, as can be seen 
with the evident reduction of serum ALT and AST activi-
ties of pretreated rats in both experimental models. While 
previous study showed that 80% aqueous-methanolic ex-
tract of A. absinthium was effective against CCl4-injury 
at the concentration of 500 mg/kg (24), our results indi-
cated improving liver function in 50 mg/kg of AA. Previ-
ous studies showed the reduction of serum ALT and AST 
levels (25,26). We elucidated the probable mechanisms of 
hepato-protection investigating further the effects of AA 
on the liver antioxidant status. The liver is a principal or-
gan involved in generation of ROS induced by drugs and 
toxic chemicals (27). In this study, our results suggested 
that AA could exert its antioxidant or radical scavenging 
activities thus preventing the formation ROS. AA admin-
istration was shown to put off decrease TTG concentra-
tion in experimental animals. AA by directly scavenging 
the free radicals and improving liver function in rats may 
increases in the glutathion (GSH) content in the rat liver 
(13). The previous studies showed antioxidant proper-
ties of AA, too (15). In addition, to more clarify possible 
mechanisms of hepato-protective activity of AA, future 
studies are required investigating the molecular and cel-
lular mechanisms in oxidative toxic stress pathways. 
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